Enfusion Stock Widgets and Gadgets
| ENFN Stock | USD 10.02 0.11 1.09% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ENFN Enfusion
- Latest Enfusion Third Quarter 2024 Earnings Misses Expectations
- ENFN 10.02 -0.11
- Low 9.94
- High 10.25
- Alpha 0.18
- Beta 1.19
- Return On Equity 0.0548
- Return On Asset 0.0592
- Profit Margin 0.02 %
- Operating Margin 0.06 %
- Current Valuation 918.44 M
- Shares Outstanding 94.37 M
- Shares Owned By Insiders 5.52 %
- Shares Owned By Institutions 96.78 %
- Number Of Shares Shorted 1.02 M
- Price To Earning 0.11 X
- Price To Book 13.52 X
- Price To Sales 4.85 X
- Revenue 174.53 M
- Gross Profit 103.25 M
- EBITDA 21.93 M
- Net Income 9.25 M
- Cash And Equivalents 56.56 M
- Cash Per Share 0.84 X
- Total Debt 15.44 M
- Current Ratio 9.17 X
- Book Value Per Share 0.75 X
- Cash Flow From Operations 25.63 M
- Short Ratio 2.26 X
- Earnings Per Share 0.04 X
- Price To Earnings To Growth 2.35 X
- Target Price 9.61
- Number Of Employees 1.1 K
- Beta 0.93
- Market Capitalization 945.61 M
- Total Asset 108.97 M
- Retained Earnings (172.93 M)
- Working Capital 49.54 M
- Net Asset 108.97 M
- Accumulation Distribution 0.0302
- Daily Balance Of Power (0.35)
- Rate Of Daily Change 0.99
- Day Median Price 10.09
- Day Typical Price 10.07
- Market Facilitation Index 0.31
- Price Action Indicator (0.13)
- Period Momentum Indicator (0.11)
- Relative Strength Index 61.58
Market Snapshot Widget Example
DAX Index Germany | 19,426 0.85 | |
Taiwan Weighted Taiwan | 22,299 0.16 | |
PSI 20 Stock Portugal | 6,431 0.20 | |
CROBEX Croatia | 3,159 0.26 | |
Budapest SE Hungary | 78,374 0.83 | |
IDX 30 Jakarta Indonesia | 447.75 0.92 | |
ISEQ 20 Price Ireland | 1,594 0.58 | |
NYSE Comp USA | 20,210 0.05 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,106 1.00 | |
IPC MEXICO Mexico | 49,861 0.05 | |
KL Technology Malaysia | 58.73 1.56 | |
IBEX 35 Index Spain | 11,611 0.27 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,529 0.63 | |
SPASX Dividend Opportunities Australia | 1,696 0.33 | |
HNX 30 Vietnam | 474.27 0.32 | |
Bucharest BET-NG Romania | 1,209 0.20 | |
AMS Small Cap Netherlands | 1,215 3.41 | |
Oslo Exchange Mutual Norway | 1,413 0.06 | |
BEL Small Belgium | 8,045 0.09 | |
Basic Materials Brazil | 5,771 0.17 | |
Swiss Leader Price Switzerland | 1,929 0.49 | |
Fondo Mutuo ETF Chile | 1,362 0.28 | |
Athens General Comp Greece | 1,404 0.01 | |
Stock Exchange Of Thailand | 1,428 0.17 | |
PX Prague Stock Czech Repub | 1,689 0.35 | |
THE PHILIPPINE STOCK Philippines | 6,639 0.96 | |
WIG 30 Poland | 2,801 0.2 | |
BIST Electricity Turkey | 489.17 0.36 |
Investing Ideas
In addition to having Enfusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Enfusion
Compare Enfusion To Peers
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.